Novavax (NVAX) Climbs 13% After Filing For UK Authorization of its COVID-19 Vaccine

October 27, 2021 8:59 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Novavax (NASDAQ: NVAX) Climbs 13% After Filing For UK Authorization of its COVID-19 Vaccine



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Momentum Movers, Trader Talk